Funding to accelerate development and commercialization of company’s breakthrough blepharoplasty surgery device John Garland has been appointed as Chief Commercial Officer BEND, Ore., July 23, 2024–(BUSINESS…
Funding to accelerate development and commercialization of company’s breakthrough blepharoplasty surgery deviceJohn Garland has been appointed as Chief Commercial OfficerBEND, Ore., July 23, 2024–(BUSINESS WIRE)–Oseru, a…